{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-23-034827","form_type":"8-K","ticker":"BKYI","cik":"0001019034","company_name":"BIO KEY INTERNATIONAL INC","filed_at":"2023-12-19T23:59:59+00:00","discovered_at":"2026-05-14T18:03:27.895935+00:00","generated_at":"2026-06-07T10:17:45.197851+00:00","sec_items":["3.03","5.03","5.02","5.07","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"BIO-key approves 1-for-18 reverse stock split effective Dec 21 to regain Nasdaq minimum bid price compliance","bullets":["Stockholders approved reverse split at ratio 1-for-6 to 1-for-20; Board set final ratio at 1-for-18.","Reverse split effective 5:00 p.m. ET Dec 20; shares trade split-adjusted Dec 21 under new CUSIP 09060C507.","Outstanding shares reduced from ~16.9M to ~941,000; no fractional shares issued, rounded up to nearest whole.","Stockholders also approved 2023 Stock Incentive Plan authorizing up to 6M shares of common stock.","CEO states reverse split positions stock for ongoing Nasdaq compliance as company executes growth goals."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-23-034827","json":"https://secwatch.observer/filing/0001437749-23-034827.json","markdown":"https://secwatch.observer/filing/0001437749-23-034827.md","text":"https://secwatch.observer/filing/0001437749-23-034827.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1019034/000143774923034827/0001437749-23-034827-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1019034/000143774923034827/bkyi20231218_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-07T10:17:45.197851+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"4edd5fb865f6692ddfc10af98ba4284fa8fede90","claim":"BIO KEY INTERNATIONAL INC: Approved amendment to Certificate of Incorporation to effect a 1-for-18 reverse stock split, effective December 20, 2023 (effective 2023-12-20).","evidence_excerpt":"At the above referenced Special Meeting, stockholders of the Company approved an amendment to the Company’s Certificate of Incorporation, as amended, to effect a reverse stock split of the Common Stock in the range of 1-for-6 to 1-for-20, with the final decision of whether to proceed with the reverse stock split and the exact ratio and timing of the reverse stock split to be determined by the Board, in its discretion, no later than December 22, 2023","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1019034/000143774923034827/0001437749-23-034827-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"charter amendment"},{"label":"Effective","value":"2023-12-20"}],"fact_type":"governance_change"},{"claim_id":"c69c4ccb2a0c6470eb356735b0640d64426e3bda","claim":"BIO KEY INTERNATIONAL INC shareholders approved Proposal 1: Amendment to the Certificate of Incorporation to effect a reverse stock split at a ratio between 1-for-6 and 1-for-20 at the 2023-12-14 meeting.","evidence_excerpt":"The final voting results were as follows: Votes For Votes Against Abstentions Broker Non-Votes 6,139,952 1,283,994 31,140 -","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1019034/000143774923034827/0001437749-23-034827-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"charter amendment"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-12-14"}],"fact_type":"shareholder_vote"},{"claim_id":"f078a560da35d571fdf9c03e22f7bd7799c466e4","claim":"BIO KEY INTERNATIONAL INC shareholders approved Proposal 2: BIO-key International, Inc. 2023 Stock Incentive Plan at the 2023-12-14 meeting.","evidence_excerpt":"The final voting results were as follows: Votes For Votes Against Abstentions Broker Non-Votes 3,869,452 856,044 26,708 2,702,882","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1019034/000143774923034827/0001437749-23-034827-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"equity plan"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-12-14"}],"fact_type":"shareholder_vote"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}